Resources

Publish Date
Public Comments
C4IP Comments RE: Foreign Nations Freeloading on American-Financed Innovation (USTR-2025-0011)
Public Comments
C4IP Comments RE: Draft Guidance on the Medicare Drug Price Negotiation Program
Issue Briefs
Drug Competition Enhancement Act
Issue Briefs
Affordable Prescriptions for Patients Act
Government AgendaReports
Reaffirm and Refine: A Government Agenda for Intellectual Property (Edition 2)
Congressional Innovation ScorecardReports
The Congressional Innovation Scorecard: Second Edition
Letters
C4IP Letter to the Office of Science and Technology Policy RE: IP and Innovation
Letters
C4IP Letter to Senators Thom Tillis and Chris Coons RE: PERA and PREVAIL Act
Letters
C4IP Letter to European Commission RE: General Pharmaceutical Legislation and Patent Package
Letters
C4IP Letter to Administration RE: 2022 PTAB Guidance Withdrawal and Interim Guidelines
Letters
C4IP Letter to Senate Judiciary Committee RE: Hearing on April 3, 2025
Public Comments
C4IP Comments RE: The World Intellectual Property Organization Treaty on Intellectual Property, Genetic Resources and Associated Traditional Knowledge (PTO-C-2024-0048)
Resources:

Resources:

C4IP Comments RE: Foreign Nations Freeloading on American-Financed Innovation (USTR-2025-0011),

06/27/2025

Resources:

Resources:

C4IP Comments RE: Draft Guidance on the Medicare Drug Price Negotiation Program,

06/26/2025

Resources:

Resources:

Drug Competition Enhancement Act,

06/25/2025

Resources:

Resources:

Affordable Prescriptions for Patients Act,

06/24/2025

Resources:

Resources:

Reaffirm and Refine: A Government Agenda for Intellectual Property (Edition 2),

06/11/2025

Resources:

Resources:

The Congressional Innovation Scorecard: Second Edition,

06/10/2025

Resources:

Resources:

C4IP Letter to the Office of Science and Technology Policy RE: IP and Innovation,

05/09/2025

Resources:

Resources:

C4IP Letter to Senators Thom Tillis and Chris Coons RE: PERA and PREVAIL Act,

05/01/2025

Resources:

Resources:

C4IP Letter to European Commission RE: General Pharmaceutical Legislation and Patent Package,

04/23/2025

Resources:

Resources:

C4IP Letter to Administration RE: 2022 PTAB Guidance Withdrawal and Interim Guidelines,

04/18/2025

Resources:

Resources:

C4IP Letter to Senate Judiciary Committee RE: Hearing on April 3, 2025,

04/02/2025

Resources:

Resources:

C4IP Comments RE: The World Intellectual Property Organization Treaty on Intellectual Property, Genetic Resources and Associated Traditional Knowledge (PTO-C-2024-0048),

03/18/2025

Scroll to Top